Clostridial neurotoxins (tetanus and seven serotypes of botulinum neurotoxin) each block vesicular neurotransmitter release by cleaving specific proteins implicated in synaptic vesicle fusion with the presynaptic membrane. These toxins are important therapeutic agents for a number of neurologic disorders including cerebral palsy and are valuable tools for understanding neurotransmitter release, membrane trafficking, and protein sorting, transport, and targeting. We study the presynaptic action of the toxins using biochemical and morphologic techniques in primary cell cultures of fetal mouse spinal cord. Both A and E serotypes of BoNT cleave the neuronal protein SNAP-25, although BoNT A remains catalytically active within the synaptic terminal for a much longer time, suggesting differential trafficking of these toxins. Uptake of BoNT into spinal cord neurons in cell culture is enhanced greatly by potassium stimulation, implicating recycling synaptic vesicles as the uptake compartment. Movement of toxin across the vesicle membrane into the neuronal cytosol requires low intravesicular pH. Concanamycin A inhibits vacuolar-ATPase, preventing vesicle acidification. This drug traps toxin within vesicles allowing study of the synchronized translocation of toxin across the vesicle membrane. Pretreating cultures with concanamycin prevents cleavage of SNAP-25 by both BoNTs. Addition to cultures of concanamycin at times up to 15 min after toxin exposure completely abrogated BoNT/A action but did not prevent translocation of BoNT/E even when added immediately after toxin exposure. This suggests that BoNT/E trafficking proceeds beyond a pH-sensitive step more rapidly than BoNT/A. Concanamycin has no effect when added 40 min after toxin exposure, indicating that translocation of both toxins is complete by this time. This study suggests that synaptic vesicle recycling mediates uptake of BoNT/A and /E, and that these two toxin serotypes are trafficked differently after uptake. We also have monitored synaptic vesicle endocytosis and exocytosis by the quantitative kinetic measurement of synaptic staining and destaining with fluorescent FM dyes. Both BoNT A-blocked and untreated cultures are stained with FM2-10 during 5 min of potassium depolarization in the presence of dye. BoNT A treated cultures, which take up about 50% less FM dye than controls, lose only about 50% on destaining and show markedly different destaining kinetics. Current studies using electron microscopy are aimed at defining the relationship between synaptic vesicle exo- and endocytosis particularly as modified by BoNT A.

Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
2003
Total Cost
Indirect Cost
Name
U.S. National Inst/Child Hlth/Human Dev
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Keller, James E; Cai, Fang; Neale, Elaine A (2004) Uptake of botulinum neurotoxin into cultured neurons. Biochemistry 43:526-32
Neale, Elaine A (2003) Moving across membranes. Nat Struct Biol 10:2-3
Neale, Edward J; Elliott, David J S; Hunter, Malcolm et al. (2003) Evidence for intersubunit interactions between S4 and S5 transmembrane segments of the Shaker potassium channel. J Biol Chem 278:29079-85
Goodnough, Michael C; Oyler, George; Fishman, Paul S et al. (2002) Development of a delivery vehicle for intracellular transport of botulinum neurotoxin antagonists. FEBS Lett 513:163-8
Keller, J E; Neale, E A (2001) The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A. J Biol Chem 276:13476-82
Neale, E A; Bowers, L M; Jia, M et al. (1999) Botulinum neurotoxin A blocks synaptic vesicle exocytosis but not endocytosis at the nerve terminal. J Cell Biol 147:1249-60
Williamson, L C; Bateman, K E; Clifford, J C et al. (1999) Neuronal sensitivity to tetanus toxin requires gangliosides. J Biol Chem 274:25173-80
Keller, J E; Neale, E A; Oyler, G et al. (1999) Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett 456:137-42